Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea
Jeongha Mok, Hyungseok Kang, Won‐Jung Koh, Byung Woo Jhun, Jae‐Joon Yim, Nakwon Kwak, Taehoon Lee, Bohyoung Kang, et al. (9 authors)
European Respiratory Journal · 2019-07
Abstract
<b>The optimised use of delamanid combined with effective repurposed drugs could achieve a high treatment success rate, even in pre-extensively drug-resistant (XDR)-TB and XDR-TB patients</b>http://bit.ly/2plvEOT
MeSH terms
- Medicine
- Extensively drug-resistant tuberculosis
- Internal medicine
- Intensive care medicine